6ŒŽ30“úi“yj |
|
Opening Remarks |
|
|
|
|
“¡àV@—²•v |
2007”N“xŒ¤‹†‰ï ‰ï’·^
i“Æj‘—§•a‰@‹@\ŽOd•a‰@ —Õ°Œ¤‹†•” |
|
|
|
|
|
|
Session 1 |
|
À@’· |
ŽRŒû@³—Y |
“Œ‹ž‘åŠwˆãŠw•”•‘®•a‰@ ƒAƒŒƒ‹ƒM[ƒŠƒEƒ}ƒ`“à‰È |
|
|
|
1-1 |
ŽÀŒ±“Iƒ}ƒEƒXS‹Ø‰Š‚̉ŠÇ×–EZ‚É‚¨‚¯‚éJanus kinaseiJAKj‚Ì–ðŠ„ |
|
|
|
•½àV@«’j |
‘åãˆã‰È‘åŠw ‘æ3“à‰È |
|
|
|
1-2 |
OAŠ´ìƒ‚ƒ‹ƒ‚ƒbƒg‚Ì‹CŠÇ‚É‚¨‚¯‚éƒoƒjƒƒCƒhŽó—e‘̂ɂ‚¢‚Ä |
|
|
|
“nç³@’¼l |
¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw ŒÄ‹zŠíEŠ´õÇ“à‰È |
|
|
|
1-3 |
šb‘§ƒ‚ƒfƒ‹ƒ}ƒEƒX‚É‚¨‚¯‚éConserved noncoding sequence 1iCNS-1j‚̉ðÍ |
|
|
|
ŠŽR —Yˆê˜Y |
i“Æj‘—§•a‰@‹@\ ‘Š–ÍŒ´•a‰@ —Õ°Œ¤‹†ƒZƒ“ƒ^[ |
|
|
|
|
|
|
|
|
Session 2 |
|
À@’· |
‰Á“¡@•F |
ŒQ”nŒ§‰q¶ŠÂ‹«Œ¤‹†Š |
|
|
|
2-1 |
ƒqƒg––½ŒŒT×–E‚É‚¨‚¯‚éTh1/Th2•ª‰»‚Ì•sŠ®‘S«‚Æ‚»‚Ì—vˆö |
|
|
|
_À@@C |
“Œ‹ž“s—Õ°ˆãŠw‘‡Œ¤‹†Š ‰Ô•²ÇƒvƒƒWƒFƒNƒg |
|
|
|
2-2 |
ƒqƒXƒgƒ“’EƒAƒZƒ`ƒ‹‰»y‘f‘jŠQ–ò‚É‚æ‚é FIP1L1-PDGFRƒ¿Œ¸‹@˜‚̉ðÍ |
|
|
|
ÎŒ´@Œ¤Ž¡ |
“Œ–k‘åŠw ‘åŠw‰@–òŠwŒ¤‹†‰È ‹@”\•ªŽq¶‰»Šw•ª–ì |
|
|
|
2-3 |
‹CŠÇŽxšb‘§‚É‚¨‚¯‚éDŽ_‹…‹@”\‚ɑ΂·‚éHGF‚ÌŒø‰Ê |
|
|
|
ˆÉ“¡@@˜j |
H“c‘åŠw ˆãŠw•” —Õ°ŒŸ¸ˆãŠw |
|
|
|
|
|
|
|
|
|
|
|
Session 3 |
|
À@’· |
‘å‹v•Û Šì—Y |
ˆã—Ö@lm—Y‰ï •ä‚•a‰@ |
|
|
|
3-1 |
ŒŒŠÇ“à”ç×–E‚ÌDŽ_‹…Ú’…—U“±”\‚É‚¨‚æ‚Ú‚·IFN-ƒ¿/ƒÀ‚Ìì—p |
|
|
|
¬—Ñ@ˆÐm |
é‹Êˆã‰È‘åŠw ŒÄ‹zŠí“à‰È |
|
|
|
|
|
|
|
|
3-2 |
Budesonide/formoterol‚ÍŠˆ«‰»DŽ_‹…‚ÌÚ’…”\‚ðCü‚µ‚È‚¢‚ªAŠˆ«‰»—U“±Œã’PŠj‹…‚ÌIL-5ARANTESATNF-ƒ¿ŽY¶‚ð—}§‚·‚é |
|
|
|
ž[@@’ms |
é‹Êˆã‰È‘åŠw‘‡ˆã—ÃZƒ“ƒ^[ ŒÄ‹zŠí“à‰È |
|
|
|
3-3 |
ƒAƒŒƒ‹ƒM[«‰ŠÇ‚É‚¨‚¯‚éPPARƒÁ‚ÌDŽ_‹…Ú’…”\§Œä |
|
|
|
ç—t@‹Ml |
H“c‘åŠw ˆãŠw•” —Õ°ŒŸ¸ˆãŠw |
|
|
|
|
|
|
|
|
|
|
|
|
|
Session 4 |
|
À@’· |
‰i“c@@^ |
é‹Êˆã‰È‘åŠwˆãŠw•” ŒÄ‹zŠí“à‰È |
|
|
|
4-1 |
D’†‹…—R—ˆƒvƒƒeƒA[ƒ[‚É‚æ‚éDŽ_‹…‚ÌŠˆ«‰» |
|
|
|
–ìŠÔ@áŽq |
i“Æj‘—§•a‰@‹@\ŽOd•a‰@ —Õ°Œ¤‹†•” |
|
|
|
4-2 |
DŽ_‹…‹@”\‚É‚¨‚¯‚éƒzƒXƒzƒŠƒp[ƒ[C‚Ì–ðŠ„ |
|
|
|
²–ì ˆÀŠóŽq |
‹ß‹E‘åŠw ˆãŠw•” ŒÄ‹zŠíEƒAƒŒƒ‹ƒM[“à‰È |
|
|
|
4-3 |
Interferon-ƒÁ‚ÍTh2ƒTƒCƒgƒJƒCƒ“‚É‚æ‚éDŽ_‹…‚Ì×–E“àƒVƒOƒiƒ‹•ªŽq‚̃Šƒ“Ž_‰»‚ð˜´i‚·‚é |
|
|
|
ŽRŒû@‹MŽj |
ŒQ”nŒ§‰q¶ŠÂ‹«Œ¤‹†Š |
|
|
|
|
|
|
|
|
Session 5 |
|
À@’· |
‘å–ì@@ŒM |
“Œ –k–ò‰È‘åŠw •a‘Ô¶—Šw‹³Žº |
|
|
|
5-1 |
IL-5ˆâ“`Žq“±“ü‚ÍDŽ_‹…‘‘½‚ð—U“±‚µA‚»‚ÌŒã‚ÌRŒ´“ÁˆÙ“I–Ɖu‰ž“š‚ð—}§‚·‚é |
|
|
|
’†ž@ˆê”V |
“Œ‹ž‘åŠw ˆãŠw•” ƒAƒŒƒ‹ƒM[EƒŠƒEƒ}ƒ`“à‰È |
|
|
|
5-2 |
TAT-PTEN×–E“à“±“ü‚É‚æ‚éDŽ_‹…¶‘¶‚Æ—V‘–‚Ì—}§@ |
|
|
|
‘«—§@“N–ç |
’é‹ž‘åŠw ˆãŠw•” “à‰ÈŠwuÀ |
|
|
|
5-3 |
DŽ_‹…«è÷—±’`”’Major basic proteiniMBPj‚ÍRespiratory syncytial virusiRSVj‚É‚æ‚é‹C“¹ã”ç×–E‚̃Aƒ|ƒg[ƒVƒX‚¨‚æ‚Ñ‹C“¹‰ŠÇ‚ð‘‹‚·‚é |
|
|
|
Ήª@‘å¬ |
ŒQ”nŒ§‰q¶ŠÂ‹«Œ¤‹†Š |
|
|
|
|
|
|
|
|
5-4 |
ƒqƒgD‰–Šî‹…‚ÌFas‚ð‰î‚µ‚½Apoptosis‚Ì—U“±‚ɂ‚¢‚Ä |
|
|
|
¼–{@Œ’Ž¡ |
‘—§¬ˆçˆã—ÃZƒ“ƒ^[Œ¤‹†Š –ƉuƒAƒŒƒ‹ƒM[Œ¤‹†•” |
|
|
|
|
|
|
Session 6 |
|
À@’· |
Ö“¡@”Ž‹v |
‘—§¬ˆçˆã—ÃZƒ“ƒ^[Œ¤‹†Š –ƉuƒAƒŒƒ‹ƒM[Œ¤‹†•” |
|
|
|
6-1 |
^‹ÛRŒ´‚É‚æ‚é‹C“¹ã”ç×–E‚ÌMUC5AC‚Ì”Œ» |
|
|
|
¬ŒF@@„ |
Œcœä‹`m‘åŠw ˆãŠw•” ŒÄ‹zŠí“à‰È |
|
|
|
6-2 |
ƒqƒg‹CŠÇŽx•½ŠŠ‹Ø×–E‚Ì•ï–„”|—{ƒRƒ‰[ƒQƒ“ƒQƒ‹‚ð—p‚¢‚½ŽûkŽÀŒ±Œn‚ÌŠm—§ |
|
|
|
–k‘º@‹IŽq |
i“Æj‘—§•a‰@‹@\ ‘Š–ÍŒ´•a‰@ —Õ°Œ¤‹†ƒZƒ“ƒ^[ |
|
|
|
6-3 |
¸_“IƒXƒgƒŒƒX—U”«šb‘§‚É‚¨‚¯‚é’†•_ŒoŒnƒÊ-ƒIƒsƒIƒCƒhŽó—e‘Ì‚ÌŠÖ—^‚ƖƉu‰ž“šCü |
|
|
|
‰œŽR@D |
“Œ–k–ò‰È‘åŠw •a‘Ô¶—Šw‹³Žº |
|
|
|
|
|
|
Session 7 |
|
À@’· |
“Œ“c@—L’q |
‹ß‹E‘åŠwˆãŠw•”•‘®•a‰@ ŒÄ‹zŠíEƒAƒŒƒ‹ƒM[“à‰È |
|
|
|
7-1 |
ƒXƒM‹}‘¬–Ɖu—Ö@‚É‚æ‚éD‰–Šî‹…CD203c”Œ»•Ï‰»‚ÌŒŸ“¢ |
|
|
|
’·”ö ‚݂Â٠|
i“Æj‘—§•a‰@‹@\ ŽOd•a‰@ —Õ°Œ¤‹†•” |
|
|
|
7-2 |
ƒXƒMŒ¸Š´ì—Ö@‚É‚¨‚¯‚錌´’†blocking antibody‚ÉŠÖ‚·‚é‹@”\‰ðÍ |
|
|
|
ìã@ˆ»Žq |
“Œ‹ž‘åŠw ˆãŠw•” ƒAƒŒƒ‹ƒM[EƒŠƒEƒ}ƒ`“à‰È |
|
|
|
7-3 |
ƒXƒ^ƒ`ƒ“‚͔얞זE‚©‚ç‚̃TƒCƒgƒJƒCƒ“ŽY¶‚ð—}§‚·‚é |
|
|
|
‰ÁX”ü Vˆê˜Y |
ç—t‘åŠw ‘åŠw‰@ˆãŠwŒ¤‹†‰@ ˆâ“`Žq§ŒäŠw |
|
|
|
|
|
|
Session 8 |
|
À@’· |
X@@»•v |
i“Æj‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@
—Õ°Œ¤‹†ƒZƒ“ƒ^[ æ’[‹ZpŠJ”Œ¤‹†•” |
|
|
|
8-1 |
‹CŠÇŽxšb‘§Š³ŽÒ‚Ì––½ŒŒ‚¨‚æ‚ьċC‹Ãk‰t‚ð—p‚¢‚½Ž_‰»ƒXƒgƒŒƒX•]‰¿ |
|
|
|
—é–Ø T‘¾˜Y |
º˜a‘åŠw ˆãŠw•” ‘æˆê“à‰È |
|
|
|
8-2 |
Churg-Strauss syndromeiCSSj‚Ì•a‘ÔŒ`¬‚ւ̧Œä«T×–E‚ÌŠÖ—^‰¿ |
|
|
|
âV“¡@”ŽŽm |
i“Æj‘—§•a‰@‹@\ ‘Š–ÍŒ´•a‰@ —Õ°Œ¤‹†ƒZƒ“ƒ^[ |
|
|
|
8-3 |
DŽ_‹…«•›•@o‰Š‚Ì—\Œã’²¸|ŽèpŒã5”N‚ÌŒo‰ßŠÏŽ@‚©‚ç| |
|
|
|
¼˜e@—R“T |
“Œ‹žŽœŒb‰ïˆã‰È‘åŠw ˆãŠw•” Ž¨•@ˆôA‰ÈŠw‹³Žº |
|
|
|
|
|
|
Closing Remarks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|